GREENE MEMORIAL HOSPITAL INC.
1. Target Overview & Investment Thesis
GREENE MEMORIAL HOSPITAL INC. is a 13-bed under-performing / distressed in GREENE, OH with $33.4M in net patient revenue and a -17.9% operating margin. The hospital serves a payer mix of 28.0% Medicare, 3.9% Medicaid, and 68.1% commercial.
Thesis: Turnaround. Our ML models identify $2.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -17.9% to -10.6% (+736bps).
| Net Revenue HCRIS | $33.4M |
| Current EBITDA COMPUTED | $-6.0M |
| Operating Margin COMPUTED | -17.9% |
| Occupancy HCRIS | 31.0% |
| Revenue / Bed COMPUTED | $2.6M |
| Net-to-Gross HCRIS | 17.7% |
| Distress Probability ML | 48.8% |
2. Market Context & Competitive Position
OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of -17.9% places it below the state median. Among 49 size-comparable peers (6-26 beds), the median margin is -1.9%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (6-26), prioritizing same-state peers. 49 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GREENE MEMORIAL HOSPITAL INC. (Target) | OH | 13 | $33.4M | -17.9% |
| THE SURGICAL HOSPITAL AT SOUTH | OH | 24 | $166.6M | -3.1% |
| GALION COMMUNITY HOSPITAL | OH | 25 | $128.2M | 16.6% |
| FULTON COUNTY HEALTH CENTER | OH | 25 | $95.2M | -7.4% |
| DEFIANCE HOSPITAL INC. | OH | 25 | $78.6M | 16.7% |
| WYANDOT MEMORIAL HOSPITAL | OH | 24 | $74.7M | 7.4% |
| SELBY GENERAL HOSPITAL | OH | 25 | $73.3M | 14.7% |
| BUCYRUS COMMUNITY HOSPITAL | OH | 25 | $73.0M | 28.9% |
| UH GENEVA MEDICAL CENTER | OH | 25 | $61.6M | 11.0% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $701K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $668K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $661K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $406K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $21K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-6.0M |
| + RCM Uplift | +$2.5M |
| Pro Forma EBITDA | $-3.5M |
| Current Margin | -17.9% |
| Pro Forma Margin | -10.6% |
| WC Released (1x) | $1.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-9.2M | $-14.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-9.2M | $-19.4M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-8.3M | $-14.3M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-8.3M | $-18.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-10.1M | $-24.2M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-10.1M | $-30.0M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 31.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 49 hospitals with 6-26 beds
- Same-state prioritization (n=51)
- Comp margins: P25=-10.6% / P50=-1.9% / P75=16.3%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.